Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Nephropathy

Clinical Trial ID NCT01292317

Rank	Title	Journal	Year	PubWeight™‹?›
1	Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.	Am J Med	1997	4.88
2	Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.	Crit Care Med	2009	4.30
3	Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings?	J Nephrol	2009	1.09
4	Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study).	BMC Nephrol	2011	0.83
5	Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study).	Sci Rep	2017	0.75